Position in BIIB
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,606,838
+$302,996 QoQ
Shares Held
7,437
+4.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#372
of 1,031 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Generali Investments, Management Co LLC holds $49,014,742 across 9 Drug Manufacturers - General names. BIIB ranks #8 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,220 | $12,258,175 | |
| 2 | JNJ |
Johnson & Johnson
|
32,881 | $8,350,787 | |
| 3 | MRK |
Merck & Co., Inc.
|
58,747 | $7,548,989 | |
| 4 | ABBV |
AbbVie Inc.
|
29,767 | $7,490,567 | |
| 5 | PFE |
Pfizer Inc
|
189,601 | $4,565,592 | |
| 6 | AMGN |
Amgen Inc
|
9,966 | $3,608,887 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
20,496 | $2,589,464 | |
| 8 | BIIB |
Biogen Inc.
This page
|
7,437 | $1,606,838 |
All Filings in BIIB
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,606,838 | 7,437 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $1,303,842 | 7,112 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $1,931,314 | 10,974 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,396,597 | 9,970 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $246,407 | 1,962 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $268,480 | 1,962 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $409,519 | 2,678 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||